155 related articles for article (PubMed ID: 9299460)
21. Indeno[1,2-c]isoquinolines as enhancing agents on all-trans retinoic acid-mediated differentiation of human myeloid leukemia cells.
Kim SH; Oh SM; Song JH; Cho D; Le QM; Lee SH; Cho WJ; Kim TS
Bioorg Med Chem; 2008 Feb; 16(3):1125-32. PubMed ID: 18024133
[TBL] [Abstract][Full Text] [Related]
22. Effects of novel uracil analogs on proliferation and differentiation of human myeloid leukemia cells.
Makishima M; Honma Y; Hozumi M; Sampi K; Hattori M; Ishikawa I; Ogura H; Motoyoshi K
Exp Hematol; 1992 Aug; 20(7):879-85. PubMed ID: 1321051
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of dendritic cell markers by all-trans retinoic acid on human acute promyelocytic leukemic cell line.
Park HY; Park JY; Kim JW; Lee MJ; Jang MJ; Lee SY; Baek DW; Park YM; Lee SW; Yoon S; Bae YS; Kwak JY
Int Immunopharmacol; 2004 Dec; 4(13):1587-601. PubMed ID: 15454112
[TBL] [Abstract][Full Text] [Related]
24. Effect of antimetabolites and thymidine blockage on the induction of differentiation of HL-60 cells by retinoic acid or 1 alpha,25-dihydroxyvitamin D3.
Ishikura H; Okazaki T; Mochizuki T; Izumi Y; Tashima M; Sawada H; Uchino H
Exp Hematol; 1985 Nov; 13(10):981-8. PubMed ID: 3932088
[TBL] [Abstract][Full Text] [Related]
25. Adenoviral mediated gene transfer can be accomplished in human myeloid cell lines and is inhibited by all-trans retinoic acid-induced differentiation.
Tosi P; Pellacani A; Visani G; Ottaviani E; Tura S
Haematologica; 1997; 82(4):387-91. PubMed ID: 9299847
[TBL] [Abstract][Full Text] [Related]
26. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
Yu AL; Bakay B; Kung FH; Nyhan WL
Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
[TBL] [Abstract][Full Text] [Related]
27. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
Gallagher AP; Burnett AK; Bowen DT; Darley RL
Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
[TBL] [Abstract][Full Text] [Related]
28. A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
Kanatani Y; Makishima M; Ishikawa I; Ogasawara Y; Kawahara N; Motoyoshi K; Nagata N; Honma Y
Exp Hematol; 1998 Mar; 26(3):198-206. PubMed ID: 9502615
[TBL] [Abstract][Full Text] [Related]
29. All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias.
Barber N; Belov L; Christopherson RI
Leuk Res; 2008 Feb; 32(2):315-22. PubMed ID: 17561254
[TBL] [Abstract][Full Text] [Related]
30. [Experimental study of the enhancement effect of aminopeptidase N inhibitor ubenimex on the differentiation induction activity of all-trans-retinoic acid in acute promyelocytic leukemia cells and its mechanism].
Qian XJ; Lin MF
Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):445-8. PubMed ID: 17147245
[TBL] [Abstract][Full Text] [Related]
31. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
Hershfield MS; Kredich NM; Koller CA; Mitchell BS; Kurtzberg J; Kinney TR; Falletta JM
Cancer Res; 1983 Jul; 43(7):3451-8. PubMed ID: 6601986
[TBL] [Abstract][Full Text] [Related]
32. Induction of functional differentiation of a human monocytic leukemia cell line (THP-1) by retinoic acid and cholera toxin.
Hemmi H; Breitman TR
Jpn J Cancer Res; 1985 May; 76(5):345-51. PubMed ID: 2989063
[TBL] [Abstract][Full Text] [Related]
33. Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent.
Sato S; Tomoyasu S; Okabe-Kado J; Hozumi M; Tsuruoka N; Nakai S; Adachi M; Honma Y
Exp Hematol; 1996 Jan; 24(1):37-42. PubMed ID: 8536790
[TBL] [Abstract][Full Text] [Related]
34. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
Duan DS; Smith W; Sadée W; Cowan MJ
Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
[TBL] [Abstract][Full Text] [Related]
35. Antileukemic efficacy of 2-deoxycoformycin in monocytic leukemia cells.
Niitsu N; Yamamoto-Yamaguchi Y; Kasukabe T; Okabe-Kado J; Umeda M; Honma Y
Blood; 2000 Aug; 96(4):1512-6. PubMed ID: 10942399
[TBL] [Abstract][Full Text] [Related]
36. Levels of 2'-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia.
Venner PM; Glazer RI; Blatt J; Sallan S; Rivera G; Holcenberg JS; Lipton J; Murphy SB; Poplack DG
Cancer Res; 1981 Nov; 41(11 Pt 1):4508-11. PubMed ID: 6975654
[TBL] [Abstract][Full Text] [Related]
37. Changes in nucleoside transport of HL-60 human promyelocytic cells during N,N-dimethylformamide induced differentiation.
Chen SF; Cleaveland JS; Hollmann AB; Wiemann MC; Parks RE; Stoeckler JD
Cancer Res; 1986 Jul; 46(7):3449-55. PubMed ID: 3486711
[TBL] [Abstract][Full Text] [Related]
38. Differanisole A, a novel antitumor antibiotic, enhances growth inhibition and differentiation of human myeloid leukemia cells induced by 9-cis retinoic acid.
Kanatani Y; Makishima M; Asahi K; Sakurai A; Takahashi N; Motoyoshi K; Nagata N; Honma Y
Biochim Biophys Acta; 1997 Oct; 1359(1):71-9. PubMed ID: 9398087
[TBL] [Abstract][Full Text] [Related]
39. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
Tanaka M; Kimura K
Tohoku J Exp Med; 1985 Dec; 147(4):331-41. PubMed ID: 3879563
[TBL] [Abstract][Full Text] [Related]
40. Reinforcement of antitumor effect of Cordyceps sinensis by 2'-deoxycoformycin, an adenosine deaminase inhibitor.
Yoshikawa N; Nakamura K; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
In Vivo; 2007; 21(2):291-5. PubMed ID: 17436579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
